Joyo, Celestino B.
HRN: 26-65-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/29/2025
02/05/2025
IV
500mg
Q8
Ruptured Viscus
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: No